John Poulos
Fortuna: - $ al 31/05/2026
Fortuna: - $ al 31/05/2026
John Poulos currently works at Faron Pharmaceuticals Oy, as Independent Non-Executive Director from 2017, Memgen, Inc., as Director from 2020, and GNK Advisors, Inc., as President from 2016.
Mr. Poulos also formerly worked at Abbott Pharmaceutical, Inc., as Head-Pharmaceutical Licensing & Acquisitions from 2005 to 2012 and AbbVie Oy, as VP, Head-Business Development & Acquisitions from 2013 to 2016.
Mr. Poulos received his undergraduate degree and Masters Business Admin degree from Indiana University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/12/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| FARON PHARMACEUTICALS OY | Director/Miembro de la Junta | 16/05/2017 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Director/Miembro de la Junta | 18/11/2020 |
GNK Advisors, Inc. | Presidente | 01/01/2016 |
| Empresas | Cargo | Fin |
|---|---|---|
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Corporate Officer/Principal | 01/01/2016 |
Abbott Pharmaceutical, Inc. | Corporate Officer/Principal | 01/01/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Health Technology |
Abbott Pharmaceutical, Inc. | |
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
GNK Advisors, Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.